CCHR Calls for Ceasing Psychedelic Drug Trials on Military and VeteransMental health industry watchdog calls for an end to federal funding for psychedelic drug research on active-duty service members and veterans, likening it to the risky covert hallucinogenic experiments of 70 years ago.
Cease Psychedelic Drug Trials on Military and Vets The Department of Veteran Affairs has also announced new funding for research into the potential use of psychedelic substances such as MDMA (Ecstasy), psilocybin (magic mushrooms)—to treat PTSD and depression.[ CCHR says this is another example of service members and veterans being used for risky psychotropic drug experiments, a practice that dates back at least 70 years, including psychedelic drugs such as LSD. According to psychiatrist, Colin Ross writing in History of Psychiatry, "Extensive LSD testing was conducted by the U.S. Army at Edgewood Arsenal [in Maryland] and other locations from 1955 to 1967." Citing several official reports regarding this, he says, these glossed over and minimized the short and long-term side effects and complications of this testing. "However, the reports themselves document frequent, severe complications of the LSD. These side effects were regarded by the Army as having been directly caused by the LSD exposure. In view of the current resurgence of interest in hallucinogens within psychiatry, the sanitized version of the effects of LSD exposure on U.S. soldiers needs to be replaced with a more accurate account."[3] Experiments ranged from LSD to potentially lethal nerve and incapacitating agents like BZ, the latter leading to hallucinations and confusion.[4] CCHR's compelling documentary Hidden Enemy: Inside Psychiatry's Covert Agenda documents the psychiatric abuse of service members and vets. Beginning in the 1950s, the U.S. government collaborated with pharmaceutical companies, research universities, and psychiatrists to develop LSD for psychological warfare. The program exploited U.S. service members to develop hallucinogens as chemical warfare to render enemy troops mentally incapacitated. According to a 2022 article in Federal Practitioner, "This program was rife with violations of research ethics and human rights…."[6] Military settings have long been a target for psychiatric research. British military psychiatrist John Rawlings Rees, who co-founded the World Federation for Mental Health (WFMH) in 1948, stated: "The army and other fighting services form rather unique experimental groups since they are complete communities and it is possible to arrange experiments that would be very difficult to do in civilian life."[7] There was wide use of brain-damaging electroshock treatment (ECT) during World War II. Between 1943 and 1951, nearly 3,000 U.S. veterans sacrificed their frontal lobes to psychosurgery operations.[ In 2019, the Defense Advanced Research Projects Agency invested $27 million in the Focused Pharma program to develop new, rapid-acting drugs, including hallucinogens. In 2022, the VA's psychedelics program research included clinical trials.[10] Esketamine, a ketamine-compound nasal spray depression drug, was touted as the answer to veteran suicides, although the drug hasn't been proven to reduce the risk of suicide. Rather, there are reports of esketamine inducing "psychosis-like" The Food and Drug Administration's (FDA) high-risk black box on the drug's labeling warns it can cause sedation, dissociation, abuse, and misuse. By 2022, the FDA was alerting healthcare professionals to the potentially serious risks of the nasal spray, including hemodynamic [cardiovascular function] instability, emergence reactions (vivid dreams, hallucinations, or delirium), respiratory depression, and drug-induced liver injury, among others.[13] Yet, in April 2023, the Department of Veterans Affairs awarded $40 million in research funding to study the effectiveness of esketamine for veterans and others. The study involves more than 900 veterans across 25 VA sites.[14] With the staggering statistic that over 1.8 million veterans have held active prescriptions filled by a VA pharmacy for psychiatric drugs, it becomes increasingly evident that the reliance on such drugs has not proven effective in mitigating the alarming rates of veteran suicides and mental distress.[15] In June 2021, Brown University's "Costs of War" report revealed continuing startling trends in suicide rates of veterans who served in wars after the 9/11 terror attacks as well as deployments in five other spots around the world. "Active service member suicide rates have grown during the Global War on Terror to surpass any service member suicide rates since before World War II," according to the report.[16] Former sergeant Hannis Latham, who served in the U.S. Army in the 1960s in the "Green Beret" special forces, stated: "Psychiatric drugs are that one thing that makes our modern warfare so much more deadly for our returning soldiers than any past war…. Instead of creating recovery programs for returning vets where they are recognized as normal people who have been through a very abnormal experience, our vets are often prescribed antipsychotics, tranquilizers, and antidepressants and told to suck it up and pull it together." Incorporating psychedelics will merely worsen the current situation, according to CCHR. The group calls for the immediate cessation of psychotropic drug trials on military personnel and veterans. It also advocates for an end to federal funding for any further psychedelic trials or research involving active-duty service members and veterans, urging a reevaluation of priorities to ensure the well-being of those who have valiantly served our nation. [1] www.washingtontimes.com/ [2] www.military.com/ [3] pubmed.ncbi.nlm.nih.gov/ [4] www.cnn.com/ [5] www.newschannel5.com/ [6] www.ncbi.nlm.nih.gov/ [7] John Rawlings Rees, M.D., The Shaping of Psychiatry by War, 1945 [8] www.washingtonpost.com/ [9] www.telegraph.co.uk/ [10] www.ncbi.nlm.nih.gov/ [11] https://www.cchrint.org/ [12] www.medicalnewstoday.com/ [13] www.fda.gov/ [14] www.research.va.gov/ [15] news.va.gov/ [16] www.cchrint.org/ End
|
Account Phone Number